Bradley Merrill Thompson Quoted in “510(k) Modernization: FDA Floats Need to Pursue New Authority”

RAPS Regulatory Focus

Bradley Merrill Thompson, Member of the Firm in the Health Care & Life Sciences practice, in the firm’s Washington, DC, office, was quoted in RAPS Regulatory Focus, in “510(k) Modernization: FDA Floats Need to Pursue New Authority,” by Ana Mulero.

Following is an excerpt:

Plans at the US Food and Drug Administration (FDA) to “modernize” the most commonly used pathway for new medical device clearances “might require new authority,” FDA leadership said on Monday.

FDA Commissioner Scott Gottlieb and Jeff Shuren, director of FDA’s Center for Devices and Radiological Health (CDRH), issued a joint statement to announce 2018 progress on novel device approvals, pointing out that the breakthrough 510(k) is one of two submission types that was newly added to the definition of a novel device. Humanitarian device exemptions (HDEs) were added to the novel device definition also, following changes the 21st Century Cures Act of 2016made to CDRH’s Breakthrough Device program.

The statement marked the first time that FDA officials publicly acknowledged a potential need to pursue new authority as part of its proposed plans for modernizing the 510(k) process. It comes after the 510(k) modernization plans drew public scrutiny last November, partly over FDA’s current authorities.

The proposal is centered on limiting use of predicate devices to those that are no more than 10 years old to demonstrate substantial equivalence, though certain concerns around the potential impact on industry innovation remain as well. Industry pushback also cited arbitrary decisions on predicate use.

The 510(k) pathway “is the law of the land, and FDA doesn’t have the right to turn its back on the law and create a new system,” Bradley Merrill Thompson, an attorney at Washington-based law firm Epstein Becker Green, said in a recent comment to FDA. In his comment, Thompson referred to a new option for sponsors to seek 510(k) clearance in addition to traditional, abbreviated and special 510(k) submissions.